Cargando…
Whole-Brain Exploratory Analysis of Functional Task Response Following Erythropoietin Treatment in Mood Disorders: A Supervised Machine Learning Approach
A core symptom of mood disorders is cognitive impairment in attention, memory and executive functions. Erythropoietin (EPO) is a candidate treatment for cognitive impairment in unipolar and bipolar disorders (UD and BD) and modulates cognition-related neural activity across a fronto-temporo-parietal...
Autores principales: | Nielsen, Søren F. V., Madsen, Kristoffer H., Vinberg, Maj, Kessing, Lars V., Siebner, Hartwig R., Miskowiak, Kamilla W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880626/ https://www.ncbi.nlm.nih.gov/pubmed/31824247 http://dx.doi.org/10.3389/fnins.2019.01246 |
Ejemplares similares
-
Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
por: Miskowiak, Kamilla W, et al.
Publicado: (2010) -
The Effect of Recombinant Erythropoietin on Plasma Brain Derived Neurotrophic Factor Levels in Patients with Affective Disorders: A Randomised Controlled Study
por: Vinberg, Maj, et al.
Publicado: (2015) -
The BDNF Val66Met Polymorphism Has No Effect on Encoding-Related Hippocampal Response But Influences Recall in Remitted Patients With Bipolar Disorder
por: Hørlyck, Lone Diana, et al.
Publicado: (2019) -
Risk for affective disorders is associated with greater prefrontal gray matter volumes: A prospective longitudinal study
por: Macoveanu, Julian, et al.
Publicado: (2017) -
Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial
por: Petersen, Jeff Zarp, et al.
Publicado: (2018)